Sunnie S. Kim

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer”.

A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1301

N/A

0DataRank · unranked

47 citations

Hongkun Wang, Aiwu Ruth He, Jimmy J. Hwang, Brandon G. Smaglo, Sunnie S. Kim +5 more

Results from the safety lead-in for a phase II study of pembrolizumab in combination with binimetinib and bevacizumab in patients with refractory metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4031

N/A

0DataRank · unranked

8 citations

S. Lindsey Davis, Stephen Leong, Alexis D. Leal, Patrick J. Blatchford, Gurprataap Singh Sandhu +15 more

A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer

The Oncologist(2022)10.1093/oncolo/oyab046

N/A

0DataRank · unranked

51 citations

Yo-Ting Tsai, Benjamin A. Weinberg, Renee N. Donahue, Shruti U. Gandhy, Margaret E. Gatti‐Mays +14 more

A phase II study of pembrolizumab, binimetinib, and bevacizumab in patients with microsatellite-stable, refractory, metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.118

N/A

0DataRank · unranked

8 citations

Patrick J. Blatchford, Robert W. Lentz, S. Lindsey Davis, Sunnie S. Kim, Alexis D. Leal +9 more

Trial in progress: A phase II study (with safety run-in) of evorpacept (ALX148), cetuximab, and pembrolizumab in patients with refractory microsatellite-stable metastatic colorectal cancer (AGICC-ALX148 21CRC01).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps257

N/A

0DataRank · unranked

0 citations

Junxiao Hu, Patrick J. Blatchford, Todd M. Pitts, Alexis D. Leal, Sunnie S. Kim +7 more

Immune Landscape of Epstein–Barr Virus–Associated Gastric Cancer: Analysis From a Western Academic Institution

Journal of Surgical Research(2024)10.1016/j.jss.2024.01.043

N/A

0DataRank · unranked

7 citations

Danielle Gilbert, Jeffrey Kaplan, Linda van Dyk, Sunnie S. Kim, Leslie J. Berg +5 more